CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study

Clinical trial NCT01719835 · UNKNOWN

Trial details

NCT number: NCT01719835
Sponsor: Royal Marsden NHS Foundation Trust
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma NOS Anaplastic Large Cell Lymphoma, ALK-Negative Angioimmunoblastic T-cell Lymphoma Hepatosplenic Gamma/ Delta T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma

Start date: 2012-03-01
Primary completion: 2016-11-30
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.